Mortality risk in post-operative head and neck cancer patients during the SARS-Cov2 pandemic: early experiences
Purpose: The objective of this report is to outline our early experience with head and neck cancer patients in a tertiary referral center, during the SARS-Cov2 pandemic, and to describe the poor outcomes of patients who acquired the infection.
Methods: In this case series from a single-center, national tertiary referral center for head and neck cancer we describe three consecutive head and neck cancer patients who contracted SARS-Cov2 during their inpatient stay.
Results: Of the three patients described in our case series that contracted SARS-Cov2, two patients died from SARS-Cov2 related illness.
Conclusion: We have demonstrated the significant implications that SARS-Cov2 has on head and neck cancer patients, with 3 patients acquiring SARS-Cov2 in hospital, and 2 deaths in our that cohort. We propose a complete separation in the location of where these patients are being managed, and also dedicated non-SARS-Cov2 staff for their peri-operative management.
Level of evidence: IV.
History
Comments
This version of the article has been accepted for publication, after peer review (when applicable) and is subject to Springer Nature’s AM terms of use, but is not the Version of Record and does not reflect post-acceptance improvements, or any corrections. The Version of Record is available online at: https://doi.org/10.1007/s00405-020-06138-wPublished Citation
Hintze JM, Fitzgerald CW, Lang B, Lennon P, Kinsella JB. Mortality risk in post-operative head and neck cancer patients during the SARS-Cov2 pandemic: early experiences. Eur Arch Otorhinolaryngol. 2020;278(1):275-278.Publication Date
22 June 2020External DOI
PubMed ID
32572564Publisher
Springer NatureVersion
- Accepted Version (Postprint)